Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

It’s ironic—and infuriating—that we find ourselves in a disadvantaged position regarding the coronavirus vaccine since Connaught was a world leader in vaccine development and production. (Photo by THIBAULT SAVARY/AFP via Getty Images)

It’s ironic—and infuriating—that we find ourselves in a disadvantaged position regarding the coronavirus vaccine since Connaught was a world leader in vaccine development and production. (Photo by THIBAULT SAVARY/AFP via Getty Images)

Canada Is Now Paying the Price for Privatizing Its Vaccine Research and Production Lab

Unfortunately, we’ve ventured a long way from the days when we had a publicly owned and medically innovative enterprise that dazzled on the world stage and kept Canadians at the front of the line for vaccines.

Linda McQuaig

 by Toronto Star

As the Trudeau government struggles to figure out how to get a coronavirus vaccine to Canadians, one thing is clear: this task would be a lot easier if the Mulroney government hadn’t privatized Connaught Labs three decades ago.

The sale of the remarkable Connaught Labs to foreign interests made no sense back then, and it makes even less sense today.

Its consequences loom over the country, with Prime Minister Justin Trudeau acknowledging last week that Canadians won’t get the coronavirus vaccine as soon as citizens in the U.S., Britain, Germany and other countries because we no longer have sufficient domestic vaccine capabilities.

Even though our public investment paid for the original research, Canadians have no say over the products nor the price at which they are sold to us as consumers. Canada also has no share in the profits.

This will be stunning news to anyone familiar with Connaught’s groundbreaking work in developing vaccines and other medical treatments over seven decades before its privatization.

Indeed, it’s ironic — and infuriating — that we find ourselves in a disadvantaged position regarding the coronavirus vaccine since Connaught was a world leader in vaccine development and production.

If Connaught Labs still existed today, its scientists would almost certainly be involved in the quest to come up with a coronavirus vaccine, working collaboratively with other researchers — just as they played a key role in helping U.S. virologist Jonas Salk develop the polio vaccine in the 1950s.

From the early part of the 20th century, Connaught created and produced high-quality medical treatments and vaccines for Canadians, including vaccines for smallpox, tetanus, diphtheria and whooping cough, as Canadian medical historian Christopher Rutty has documented.

Connaught had so distinguished itself as a vaccine producer that when the World Health Organization (WHO) launched a global campaign to eradicate smallpox in the 1960s, it turned to Connaught for help, according to Rutty.

In that campaign, Connaught was tasked with improving standards for smallpox vaccine production throughout the Western hemisphere. Connaught scientists travelled to 12 Latin American countries to teach Connaught’s methods.

And, at WHO’s request, Connaught produced a stockpile of 25 million doses of the smallpox vaccine in case of an outbreak in Latin America.

Clearly, Connaught had ample facilities for vaccine production and had been on the cutting edge of vaccine innovation internationally.

The biotech lab was started in 1914 by Toronto doctor John G. FitzGerald who was appalled that large numbers of Canadian children were dying during a diphtheria epidemic because their parents couldn’t afford the only treatment available. FitzGerald experimented and developed an antitoxin that could treat diphtheria, and then, with lab space provided by U of T, went on to develop affordable treatments and vaccines for other deadly diseases.

Connaught Labs always put Canadian needs first. Its main customers were provincial governments, to which it provided its products at cost. Even so, Connaught managed to be financially self-sufficient, earning profits by selling its vaccines in the global market, where it outperformed U.S. and European commercial vaccine producers.

“While other vaccine producers were waning in their export and research and development activities during the early 1970s, Connaught stood out in both areas,” Rutty notes.

But, sadly, Connaught got swept up in the privatization frenzy that gripped Brian Mulroney’s Conservative government in the 1980s as it sought to please the business world by selling off some of Canada’s best publicly owned enterprises.

Today, what remains of Connaught has been absorbed into the vaccine division of foreign-owned pharmaceutical giant Sanofi.

What makes our predicament today particularly galling is that Ottawa invests roughly $1 billion a year to fund medical research by scientists at Canadian universities — without any control over the results, according to Dr. Joel Lexchin, professor emeritus at York University’s School of Health Policy and Management.

The scientists are permitted to take out patents on the products they develop (with our money), and then sell them to pharmaceutical manufacturers, who sell the products to the public — often at great profit.

Even though our public investment paid for the original research, Canadians have no say over the products nor the price at which they are sold to us as consumers. Canada also has no share in the profits.

We’ve ventured a long way, unfortunately, from the days when we had a publicly owned and medically innovative enterprise that dazzled on the world stage and kept Canadians at the front of the line for vaccines.

No longer.


© 2020 TheStar.com
Linda McQuaig

Linda McQuaig

Linda McQuaig is an author, journalist, and former NDP candidate for Toronto Centre in the Canadian federal election. She is also the author of "The Sport and Prey of Capitalists: How the Rich Are Stealing Canada's Public Wealth" (2019), "War, Big Oil and the Fight for the Planet: It's the Crude, Dude" (2006) and  (with Neil Brooks) of "Billionaires’ Ball: Gluttony and Hubris in an Age of Epic Inequality" (2012).

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

Please select a donation method:

AOC Slams Conservative Dems Who Would Rather Skip Town Than Vote to Extend Eviction Ban

"We cannot in good faith blame the Republican Party when House Democrats have the majority."

Jake Johnson ·


'A Devastating Failure': Eviction Ban Expires as House Goes on Vacation and Biden Refuses to Act

"We’re now in an eviction emergency," said Rep. Cori Bush. "Eleven million are now at risk of losing their homes at any moment. The House needs to reconvene and put an end to this crisis."

Jake Johnson ·


With Election Days Away, Bernie Sanders Headlines Get-Out-the-Vote Rally for Nina Turner

In his keynote speech, Sanders said corporate interests are pulling out all the stops to defeat Turner because "they know that when she is elected, she is going to stand up and take them on in the fight for justice."

Jake Johnson ·


Bush, Pressley, and Omar Sleep Outside Capitol to Demand Extension of Eviction Moratorium

Rep. Cori Bush, who was formerly unhoused, slammed her Democratic colleagues who "chose to go on vacation early today rather than staying to vote to keep people in their homes."

Jake Johnson ·


As Progressives Call for End to Blockade, Biden Announces More Sanctions Against Cuba

The move comes after Democratic leadership in the House blocked an amendment to roll back limits on how much money people in the United States can send to family on the island nation.

Jessica Corbett ·